In FHR-5 nephropathy the mutated FHR-5 protein is thought to promote C3 activation along surfaces within the kidney, by interfering with the ability of FH to negatively regulate glomerular complement by out-competing FH for binding to glomerular C3 (FH deregulation) (15). This evidence concerns the gene C3 and kidney disorder.